Jacek J Jóźwiak1, Krzysztof Studziński2, Tomasz Tomasik3, Adam Windak2, Mirosław Mastej4, Alberico L Catapano5, Kausik K Ray6, Dimitri P Mikhailidis7, Peter P Toth8, George Howard9, Gregory Y H Lip10, Maciej Tomaszewski11, Fadi J Charchar12, Naveed Sattar13, Bryan Williams14, Thomas M MacDonald15, Dariusz Nowak16, Łukasz Skowron17, Sławomir Kasperczyk18, Maciej Banach19. 1. Department of Family Medicine and Public Health, Faculty of Medicine, University of Opole, Oleska 48, 45-052, Opole, Poland. 2. Department of Family Medicine, Jagiellonian University Medical College, Bochenska 4, 31-061, Krakow, Poland. 3. Department of Family Medicine, Jagiellonian University Medical College, Bochenska 4, 31-061, Krakow, Poland. Electronic address: mmtomasi@cyf-kr.edu.pl. 4. Mastej Medical Center, Staszica 21, 38-200, Jasło, Poland. 5. Department of Pharmacological Sciences University of Milano and Multimedica IRCCS, Milano, Italy. 6. Imperial Centre for Cardiovascular Disease Prevention, Department of Primary Care and Public Health, Imperial College, Kensington, London, UK. 7. Department of Clinical Biochemistry, Royal Free Hospital, University College London, London, UK. 8. Cicarrone Center for the Prevention of Cardiovascular Disease, Johns Hopkins University School of Medicine, Baltimore, MD, USA; CGH Medical Center, Sterling, IL, USA. 9. Department of Biostatistics, School of Public Health of Alabama at Birmingham, AL, USA. 10. Liverpool Centre for Cardiovascular Science, University of Liverpool and Liverpool Heart & Chest Hospital, Liverpool, UK; Aalborg Thrombosis Research Unit, Department of Clinical Medicine, Aalborg University, Aalborg, Denmark. 11. Division of Cardiovascular Sciences, Faculty of Biology, Medicine and Health, University of Manchester, UK. 12. School of Health and Life Sciences, Federation University Australia, Ballarat, Victoria, Australia. 13. Institute of Cardiovascular and Medical Science, University of Glasgow, Glasgow, G128TA, UK. 14. NIHR University College London Biomedical Research Centre, University College London and University College London Hospitals NHS Foundation Trust, London, UK. 15. MEMO Research, University of Dundee, Ninewells Hospital and Medical School, Dundee, DD1 9SY, UK. 16. Municipal Hospital, Mickiewicza 12, 42-200, Czestochowa, Poland. 17. Department of Gastroenterology, Endocrinology and Internal Diseases, Military Institute of Medicine, Szaserow 128, 04-141, Warszawa, Poland. 18. Department of Biochemistry, Faculty of Medical Sciences in Zabrze, Jordana 19 41-808 Zabrze, Medical University of Silesia, Katowice, Poland. 19. Department of Hypertension, Medical University of Lodz, Rzgowska 281/289, 93-338, Łodz, Poland.
Abstract
BACKGROUND AND AIM: To estimate the prevalence of cardiovascular (CV) disease and CV risk factors among Polish patients. METHODS: A nationwide cross-sectional study, LIPIDOGRAM2015, was carried out in Poland in the 4th quarter of 2015 and 1st and 2nd quarters of 2016; 438 primary care physicians enrolled 13,724 adult patients that sought medical care in primary health care practices. RESULTS: Nearly 19% of men and approximately 12% of women had cardiovascular disease (CVD). Over 60% of the recruited patients had hypertension (HTN), >80% had dyslipidaemia and <15% of patients were diagnosed with diabetes (DM). All of these disorders were more frequent in men. In 80% of patients the waist circumference exceed norm for the European population. Less than half of the patients were current smokers or had smoked in the past. Patients with CVD had significantly higher blood pressure and glucose levels but lower low density lipoprotein-cholesterol level. CONCLUSIONS: The prevalence of CVD and CV risk factors among patients in Poland is high. CVD is more common in men than in women. The most common CV risk factors are excess waist circumference, dyslipidaemia and HTN. Family physicians should conduct activities to prevent, diagnose early and treat CVD in the primary health care population.
BACKGROUND AND AIM: To estimate the prevalence of cardiovascular (CV) disease and CV risk factors among Polish patients. METHODS: A nationwide cross-sectional study, LIPIDOGRAM2015, was carried out in Poland in the 4th quarter of 2015 and 1st and 2nd quarters of 2016; 438 primary care physicians enrolled 13,724 adult patients that sought medical care in primary health care practices. RESULTS: Nearly 19% of men and approximately 12% of women had cardiovascular disease (CVD). Over 60% of the recruited patients had hypertension (HTN), >80% had dyslipidaemia and <15% of patients were diagnosed with diabetes (DM). All of these disorders were more frequent in men. In 80% of patients the waist circumference exceed norm for the European population. Less than half of the patients were current smokers or had smoked in the past. Patients with CVD had significantly higher blood pressure and glucose levels but lower low density lipoprotein-cholesterol level. CONCLUSIONS: The prevalence of CVD and CV risk factors among patients in Poland is high. CVD is more common in men than in women. The most common CV risk factors are excess waist circumference, dyslipidaemia and HTN. Family physicians should conduct activities to prevent, diagnose early and treat CVD in the primary health care population.
Authors: Maciej Banach; Paweł Burchardt; Krzysztof Chlebus; Piotr Dobrowolski; Dariusz Dudek; Krzysztof Dyrbuś; Mariusz Gąsior; Piotr Jankowski; Jacek Jóźwiak; Longina Kłosiewicz-Latoszek; Irina Kowalska; Maciej Małecki; Aleksander Prejbisz; Michał Rakowski; Jacek Rysz; Bogdan Solnica; Dariusz Sitkiewicz; Grażyna Sygitowicz; Grażyna Sypniewska; Tomasz Tomasik; Adam Windak; Dorota Zozulińska-Ziółkiewicz; Barbara Cybulska Journal: Arch Med Sci Date: 2021-11-08 Impact factor: 3.318
Authors: Maciej Banach; Jarosław Kaźmierczak; Przemysław Mitkowski; Krystian Wita; Marlena Broncel; Mariusz Gąsior; Marek Gierlotka; Robert Gil; Piotr Jankowski; Maciej Niewada; Adam Witkowski Journal: Arch Med Sci Date: 2022-03-17 Impact factor: 3.707
Authors: Krzysztof Studziński; Tomasz Tomasik; Adam Windak; Maciej Banach; Ewa Wójtowicz; Mirosław Mastej; Maciej Tomaszewski; Dimitri P Mikhailidis; Peter P Toth; Alberico Catapano; Kausik K Ray; George Howard; Gregory Y H Lip; Fadi J Charchar; Naveed Sattar; Bryan Williams; Thomas M MacDonald; Peter E Penson; Jacek J Jóźwiak Journal: J Clin Med Date: 2021-11-30 Impact factor: 4.241
Authors: Anna Maria Witkowska; Anna Waśkiewicz; Małgorzata Elżbieta Zujko; Alicja Cicha-Mikołajczyk; Iwona Mirończuk-Chodakowska; Wojciech Drygas Journal: Nutrients Date: 2022-06-27 Impact factor: 6.706
Authors: Anne Grete Semb; Silvia Rollefstad; Eirik Ikdahl; Grunde Wibetoe; Joseph Sexton; Cindy Crowson; Piet van Riel; George Kitas; Ian Graham; Solbritt Rantapää-Dahlqvist; George Athanasios Karpouzas; Elena Myasoedova; Miguel A Gonzalez-Gay; Petros P Sfikakis; Maria G Tektonidou; Argyro Lazarini; Dimitrios Vassilopoulos; Bindee Kuriya; Carol Hitchon; Maria Simona Stoenoiu; Patrick Durez; Virginia Pascual-Ramos; Dionicio Angel Galarza-Delgado; Pompilio Faggiano; Durga Prasanna Misra; Andrew A Borg; Rong Mu; Erkin M Mirrakhimov; Diane Gheta; Karen Douglas; Vikas Agarwal; Svetlana Myasoedova; Lev Krougly; Tatiana Valentinovna Popkova; Alena Tuchyňová; Michal Tomcik; Michal Vrablik; Jiri Lastuvka; Pavel Horak; Helena Kaspar Medkova; Anne M Kerola Journal: RMD Open Date: 2021-07